The Novor team is on their way to this year’s PEGS Europe conference, from October 31 to November 4, at EPIC SANA Lisbon Hotel, Lisbon, Portugal. We are honored to have the opportunity to present our works in the Engineering Antibodies session at 12:45pm, Wednesday, November 2.
Our co-founder, Mingjie, will deliver the presentation, Antibody Protein De Novo Sequencing with LC-MS/MS. In the presentation, he will share three case studies to highlight some important issues in antibody protein sequencing.
- See through the sequence coverage illusion by gaining insights on the amino acid confidence.
- Embrace the diversity and never settle for anything shy from 100%.
- Your time is valuable, let us do the heavy lifting.
We invite you to the presentation and have live discussions with Mingjie afterwards at our booth #10.
See you in Lisbon!
Newsletter for All Things Protein Sequencing
Breakthrough Bispecific Antibody R&D Techniques, Apr 20 11:00am EST.
Talk to Our Scientists.
We Have Sequenced 5000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.
Talk to Our Scientists.
We Have Sequenced 5000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics